Caption Management’s MacroGenics MGNX Stock Holding History

Caption Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-34,400	Closed	-$146K	–	1473
2024 Q2	$146K	Buy	+34,400	New	+$335K	﹤0.01%	990
2023 Q3	–	Sell	-14,787	Closed	-$79.1K	–	1421
2023 Q2	$79.1K	Hold	14,787	–	–	﹤0.01%	990
2023 Q1	$106K	Hold	14,787	–	–	﹤0.01%	968
2022 Q4	$99.2K	Buy	+14,787	New	+$81.1K	﹤0.01%	1132
2021 Q4	–	Sell	-90,000	Closed	-$1.89M	–	1809
2021 Q3	$1.89M	Buy	90,000 +752	+0.8%	+$18.1K	0.02%	785
2021 Q2	$2.4M	Sell	89,248 -9,727	-10%	-$285K	0.03%	627
2021 Q1	$3.15M	Buy	+98,975	New	+$2.4M	0.07%	369
2020 Q1	–	Sell	-30,000	Closed	-$327K	–	986
2019 Q4	$327K	Sell	30,000 -50,000	-63%	-$495K	0.01%	684
2019 Q3	$1.02M	Buy	+80,000	New	+$1.15M	0.05%	373
2019 Q2	–	Sell	-10,000	Closed	-$172K	–	760
2019 Q1	$180K	Buy	+10,000	New	+$173K	0.01%	514

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's MGNX Position: Q3 2024 in Review

Caption Management sold out of MacroGenics (MGNX) in Q3 2024, closing a stake of 34,400 shares — an estimated $146K sold.

Caption Management first reported a position in MGNX in Q1 2019 and held it in 10 quarters. The position peaked at $3.15M in Q1 2021. 124 funds tracked by Wall St. Rank hold MGNX as of Q3 2024.

Caption Management reported no remaining MacroGenics position as of Q3 2024 after selling out during the quarter.
Caption Management sold 34,400 MacroGenics shares in Q3 2024, an estimated $146K.
Caption Management first reported a position in MacroGenics in Q1 2019 and held it in 10 quarters.
Caption Management's MacroGenics position peaked at $3.15M in Q1 2021.
124 funds tracked by Wall St. Rank held MacroGenics as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.